We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Bio Techne Corporation | NASDAQ:TECH | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
1.40 | 2.23% | 64.06 | 63.34 | 64.83 | 64.36 | 62.33 | 62.83 | 973,784 | 21:03:50 |
1. Name and Address of Reporting Person * Eansor Norman David | 2. Issuer Name and Ticker or Trading Symbol BIO-TECHNE Corp [ TECH ] |
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
_____ Director _____ 10% Owner __X__ Officer (give title below) _____ Other (specify below) President-Protein Sciences |
3. Date of Earliest Transaction
(MM/DD/YYYY)
| ||
4. If Amendment, Date Original Filed
(MM/DD/YYYY)
|
6. Individual or Joint/Group Filing
(Check Applicable Line)
_X
_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person |
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned | ||||||||||
1.Title of Security (Instr. 3) | 2. Trans. Date | 2A. Deemed Execution Date, if any |
3. Trans. Code (Instr. 8) |
4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) |
5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) | 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) | 7. Nature of Indirect Beneficial Ownership (Instr. 4) | |||
Code | V | Amount | (A) or (D) | Price |
Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) | |||||||||||||||
1. Title of Derivate Security (Instr. 3) | 2. Conversion or Exercise Price of Derivative Security | 3. Trans. Date | 3A. Deemed Execution Date, if any | 4. Trans. Code (Instr. 8) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) | 6. Date Exercisable and Expiration Date | 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) | 8. Price of Derivative Security (Instr. 5) | 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) | 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) | 11. Nature of Indirect Beneficial Ownership (Instr. 4) | ||||
Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||||||
Stock Options (Right to Buy) | $106.59 | (2) | 8/18/2023 | Common Stock | 14114 | 14114 | D | ||||||||
Stock Options (Right to Buy) | $106.59 | (3) | 8/18/2023 | Common Stock | 18819 | 18819 | D | ||||||||
Restricted Stock Units | (1) | (4) | (4) | Common Stock | 2174 | 2174 | D | ||||||||
Stock Options (Right to Buy) | $125.05 | (4) | 8/9/2024 | Common Stock | 11982 | 11982 | D | ||||||||
Stock Options (Right to Buy) | $125.05 | (5) | 8/9/2024 | Common Stock | 15976 | 15976 | D | ||||||||
Restricted Stock Units | (1) | (6) | (6) | Common Stock | 2537 | 2537 | D | ||||||||
Stock Options (Right to Buy) | $177.32 | (6) | 8/8/2025 | Common Stock | 13550 | 13550 | D | ||||||||
Stock Options (Right to Buy) | $177.32 | (7) | 8/8/2025 | Common Stock | 18066 | 18066 | D | ||||||||
Restricted Stock Units | (1) | (8) | (8) | Common Stock | 3151 | 3151 | D | ||||||||
Stock Options (Right to Buy) | $190.41 | (8) | 8/7/2026 | Common Stock | 15948 | 15948 | D | ||||||||
Stock Options (Right to Buy) | $190.41 | (9) | 8/7/2026 | Common Stock | 21265 | 21265 | D | ||||||||
Restricted Stock Units | (1) | 8/5/2020 | A | 2575 | (10) | (10) | Common Stock | 2575 | $0 | 2575 | D | ||||
Stock Options (Right to Buy) | $267.87 | 8/5/2020 | A | 11488 | (10) | 8/5/2027 | Common Stock | 11488 | $0 | 11488 | D | ||||
Stock Options (Right to Buy) | $267.87 | 8/5/2020 | A | 15318 | (11) | 8/5/2027 | Common Stock | 15318 | $0 | 15318 | D | ||||
Stock Options (Right to Buy) | $267.87 | 8/5/2020 | A | 24975 | (12) | 8/5/2027 | Common Stock | 24975 | $0 | 24975 | D | ||||
Stock Options (Right to Buy) | $267.87 | 8/5/2020 | A | 24975.0 | (13) | 8/5/2027 | Common Stock | 24975.0 | $0 | 24975.0 | D |
Reporting Owners | |||||
Reporting Owner Name / Address | |||||
Director | 10% Owner | Officer | Other | ||
Eansor Norman David 8100 SOUTHPARK WAY, A-8 LITTLETON, CO 80120 | President-Protein Sciences |
Signatures | ||
/s/ Brenda S. Furlow as Attorney-in-Fact for N. David Eansor pursuant to Power of Attorney previously filed. | 8/7/2020 | |
**Signature of Reporting Person | Date |
1 Year Bio Techne Chart |
1 Month Bio Techne Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions